Luciano Juan R has executed 42 reported transactions across two companies—Archer-Daniels-Midland (ADM) and Eli Lilly (LLY)—with a clear net selling bias. According to SEC Form 4 filings, total sales amounted to $46.6 million, dwarfing total purchases of $20 million. The most significant activity occurred in ADM, where a single transaction on February 5, 2026, involved the sale of $27.9 million in shares, followed by another $19.3 million disposition the same day. Smaller but consistent sales in ADM continued through early 2026, including a $2.4 million transaction on February 9 and a $1.6 million sale on February 13. Meanwhile, LLY transactions were far smaller in scale, typically ranging between $14,800 and $16,000 per trade, with occasional spikes like the two $220,000 sales on November 17, 2025.
The pattern suggests a strategic reduction in ADM holdings, with no recent purchases offsetting the sales. LLY transactions, while frequent, appear to be routine, possibly tied to scheduled dispositions such as tax-related or automatic sales. The most recent filings show no new buys in either stock, with the last ADM sale occurring on March 20, 2026, valued at $1.16 million, and the final LLY transactions on March 16, 2026, each worth $15,917. The data reflects a sustained divestment trend in ADM, contrasting with the smaller, periodic adjustments in LLY positions.
AI-assisted summary